Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01231412
Title Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Recruitment Completed
Gender
Phase Phase III
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

hematologic cancer

Therapies

Sirolimus

Fludarabine

Cyclosporine + Mycophenolate mofetil

Age Groups:
Covered Countries USA | DEU


No variant requirements are available.